title: Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.
abstract: The effects of anxiolytic doses of buspirone and midazolam (established in the conditioned fear test) on extracellular concentrations of glutamate, GABA, serotonin and dopamine metabolites in the hippocampus were examined in vivo, in freely moving rats. Buspirone at a dose of 1.5 mg/kg ip disinhibited rat behavior in the conditioned fear test (a freezing response) much stronger than 1.0 mg/kg of midazolam. Both drugs enhanced the local concentration of glutamate to the similar extent, and decreased the concentration of 5-hydroxyindole acetic acid (5-HIAA). Buspirone increased also the extracellular levels of dopamine metabolites: homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC). It is suggested that the changes in hippocampal glutamate probably are not directly associated with modification of rat emotional behavior after benzodiazepines and azapirones. The present results provide more arguments for the role of hippocampal 5-HT in the effects of anxiolytic drugs.
authors.affiliation: Department of Experimental and Clinical Pharmacology, Medical University, Krakowskie Przedmieście 26/28, PL 00-927 Warszawa, Poland.
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Wisłowska-Stanek
authors.forename: Adam
authors.initials: A
authors.lastname: Hamed
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Lehner
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bidziński
authors.forename: Danuta
authors.initials: D
authors.lastname: Turzyńska
authors.forename: Alicja
authors.initials: A
authors.lastname: Sobolewska
authors.forename: Jerzy
authors.initials: J
authors.lastname: Walkowiak
authors.forename: Adam
authors.initials: A
authors.lastname: Płaźnik
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D015306:Biogenic Monoamines / Q000378:metabolism*; D002065:Buspirone / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D004644:Emotions / Q000187:drug effects; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D005239:Fear / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D017551:Microdialysis; D008874:Midazolam / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
chemical_list: D000596:Amino Acids; D014151:Anti-Anxiety Agents; D015306:Biogenic Monoamines; D015102:3,4-Dihydroxyphenylacetic Acid; D018698:Glutamic Acid; D006897:Hydroxyindoleacetic Acid; D005680:gamma-Aminobutyric Acid; D008874:Midazolam; D002065:Buspirone; D006719:Homovanillic Acid